The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease

Autoimmunity Reviews

Volumn 3, Issue 2, 2004, Pages 13-20

  Freitag, Tobias ^a,d   Schulze Koops, Hendrik ^a   Niedobitek, Gerald ^a   Melino, Gerry ^b,c   Schuppan, Detlef ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Anti tissue transglutaminase antibodies; Autoantibodies; Autoimmunity; Coeliac disease; TGase 2 ( ) mice; Tissue transglutaminase

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

B LYMPHOCYTE; CELIAC DISEASE; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PATHOGENESIS; REVIEW;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CELIAC DISEASE; GTP-BINDING PROTEINS; HUMANS; LACRIMAL APPARATUS; MICE; MICE, INBRED C57BL; TRANSGLUTAMINASES;

EID: 1442299238     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00054-5     Document Type: Review

References (36)

1. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 120:2001;636-651.
2. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 119:2000;234-242.
3. Godkin A., Jewell D. The pathogenesis of celiac disease. Gastroenterology. 115:1998;206-210.
4. Ventura A., Magazu G., Gerarduzzi T., Greco L. Coeliac disease and the risk of autoimmune disorders. Gut. 49:2001;502-505.
5. Sollid L.M. Molecular basis of celiac disease. Annu Rev Immunol. 18:2000;53-81.
6. Lundin K.E., Scott H., Hansen T., et al. Gliadin-specific, HLA-DQ (alpha*0501, beta*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 178:1993;187-196.
7. Monteleone G., Pender S.L., Alstead E., et al. Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut. 48:2001;425-429.
8. Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nat Med. 3:1997;797-801.
9. Dieterich W., Laag E., Schöpper H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 115:1998;1317-1321.
10. Molberg Ø., MacAdam S.N., Korner R., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T-cells in celiac disease. Nat Med. 4:1998;713-717.
11. Van de Wal Y., Kooy Y., van Veelen P., et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T-cell reactivity. J Immunol. 161:1998;1585-1588.
12. Melino G., Candi E., Steinert P.M. Assay for transglutaminases in cell death. Method Enzymol. 322:2000;433-472.
13. Greenberg C.S., Birkbichler P.J., Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5:1991;3071-3077.
14. Piacentini M., Colizzi V. Tissue transglutaminase: apoptosis versus autoimmunity. Immunol Today. 20:1999;130-134.
15. Piredda L., Amendola A., Colizzi V., et al. Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRL lpr/lpr mice. Cell Death Differ. 4:1997;463-472.
16. Kojima S., Nara K., Rifkin D.B. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol. 121:1993;439-448.
17. Cordella-Miele E., Miele L., Mukherjee A.B. A novel transglutaminase- mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity. J Biol Chem. 265:1990;17180-17188.
18. Kim S., Jeitner T.M., Steinert P.M. Transglutaminases in disease. Neurochem Int. 40:2002;85-103.
19. Bernassola F., Federici M., Corazzari M., et al. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J. 16:2002;1371-1378.
20. De Laurenzi V., Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol. 21:2001;148-155.
21. Sárdy M., Kárpáti S., Merkl B., et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 195:2002;747-757.
22. Trapp D., Dieterich W., Wieser H., et al. Tissue transglutaminase, the celiac disease autoantigen, preferentially generates antigenic neoepitopes in γ- and ω-, but not in α-gliadins. Med Klin. 96:2001;P204. abstract, in German.
23. Sollid L.M., Molberg Ø., McAdam S., Lundin K.E.A. Autoantibodies in coeliac disease: tissue transglutaminase-guilt by association? Gut. 41:1997;851-852.
24. Vanderlugt C.J., Miller S.D. Epitope spreading. Curr Opin Immunol. 8:1996;831-836.
25. Yan J., Mamula M.J. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J Immunol. 168:2002;3188-3194.
26. Liu G.Y., Fairchild P.J., Smith R.M., et al. Low avidity recognition of self-antigen by T-cells permits escape from central tolerance. Immunity. 3:1995;407-415.
27. Halttunen T., Mäki M. Serum IgA from patients with coeliac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology. 116:1999;566-572.
28. Esposito C., Paparo F., Caputo I., et al. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut. 51:2002;177-181.
29. Dieterich W, Trapp D, Esslinger B, et al. Autoantibodies of patients with celiac disease are insufficient to block tissue transglutaminase activity. Gut, submitted for publication.
30. Jos J., Labbe F., Geny B., Griscelli C. Immunoelectron-microscopic localization of immunoglobulin A and secretory component in jejunal mucosa from children with coeliac disease. Scand J Immunol. 9:1979;441-450.
31. Karpati S., Kosnai I., Torok E., Kovacs J.B. Immunoglobulin A deposition in jejunal mucosa of children with dermatitis herpetiformis. J Invest Dermatol. 91:1988;336-339.
32. Ciccocioppo R., D'Alò S., Di Sabatino A., et al. Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease. Clin Exp Immunol. 128:2002;88-93.
33. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., et al. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol. 167:2001;2861-2868.
34. Halstensen T.S., Hvatum M., Scott H., et al. Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology. 102:1992;751-759.
35. Hadjivassiliou M., Boscolo S., Davies-Jones G.A., et al. The humoral response in the pathogenesis of gluten ataxia. Neurology. 58:2002;1221-1226.
36. Arepally G., Cines D.B. Pathogenesis of heparin-induced thrombocytopenia and thrombosis. Autoimmun Rev. 1:2002;125-132.